Table 2 The pathological features of included PNS patients
Variable | AKI group (n = 92) | No AKI group (n = 236) | t/χ2 | P |
|---|---|---|---|---|
Glomerular sclerosis | 49(53.26%) | 122(51.59%) | 2.042 | 0.105 |
Parietal cytopathic lesions | 9(9.78%) | 20(8.47%) | 1.127 | 0.092 |
Podocyte lesion score | Â | Â | 4.884 | 0.178 |
 0 | 28(30.43%) | 70(29.66%) |  |  |
 1 | 35(38.04%) | 93(39.41%) |  |  |
  ≥ 2 | 29(31.53%) | 73(30.93%) |  |  |
Basal membrane lesion | 31(33.70%) | 77(32.63%) | 1.028 | 0.097 |
Capillary plexus lesion | 40(43.48%) | 92(38.98%) | 2.144 | 0.131 |
Mesangial proliferation | 89(96.74%) | 222(94.07%) | 5.102 | 0.077 |
Tubular atrophy | Â | Â | 2.196 | 0.101 |
 No atrophy | 25(27.17%) | 62(26.27%) |  |  |
  < 5% | 31(33.70%) | 80(33.90%) |  |  |
  ≥ 5% | 36(39.13%) | 94(39.83%) |  |  |
Renal tubular casts | 81(88.04%) | 156(66.10%) | 1.947 | 0.012 |
Swelling of epithelial cells | 61(66.30%) | 139(58.90%) | 3.788 | 0.056 |
Vacuolation of epithelial cells | 17(18.48%) | 38(16.0%) | 1.664 | 0.091 |
Interstitial fibrosis | Â | Â | 4.107 | 0.106 |
 No fibrosis | 26(28.26%) | 62(26.27%) |  |  |
  < 5% | 28(30.43%) | 74(31.36%) |  |  |
  ≥ 5% | 38(41.30%) | 100(42.37%) |  |  |
Interstitial inflammatory infiltration | Â | Â | 2.082 | 0.097 |
 No infiltration | 41(44.57%) | 108(45.76%) |  |  |
  < 5% | 37(40.22%) | 98(41.53%) |  |  |
  ≥ 5% | 14(15.21%) | 30(12.71%) |  |  |